Vestal Point Capital, LP Roivant Sciences Ltd. Transaction History
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
A detailed history of Vestal Point Capital, LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Vestal Point Capital, LP holds 1,250,000 shares of ROIV stock, worth $13.4 Million. This represents 0.88% of its overall portfolio holdings.
Number of Shares
1,250,000Holding current value
$13.4 Million% of portfolio
0.88%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
329Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$705 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$665 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$513 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$473 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$379 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.55B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...